Systemic Inflammatory Markers in B-cell Neoplasm

NCT06847529 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-03-12

No results posted yet for this study

Summary

This study was to evaluate the role of systemic inflammatory markers in predicting outcome for patients with B cell neoplasm

Conditions

  • B-cell Neoplasm

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Alaa El-Din Abdel Moneim El-Sayed, Doctor · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-22
Primary Completion
2025-11-30
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06847529 on ClinicalTrials.gov